June 18, 2024
June 18, 2024
Categories

Dr. Barbara Burtness and colleagues highlight progress in head and neck cancer MRD at ASCO, but caution that results remain preliminary (free registration is required to view this article)

Do you like it?
Read more
June 14, 2024
June 14, 2024
Categories

E1910 trial leads to an FDA approval in B-cell acute lymphoblastic leukemia (B-ALL)

Do you like it?
Read more
June 13, 2024
June 13, 2024
Categories

Nivolumab fails to benefit esophageal cancer treatment in the EA2174 trial: Dr. Jennifer Eads

Do you like it?
Read more
June 13, 2024
June 13, 2024
Categories

Dr. Jennifer Eads on nivolumab plus neoadjuvant chemoradiation in esophageal/GEJ cancer (trial EA2174)

Do you like it?
Read more
June 13, 2024
June 13, 2024
Categories

Personalizing chemotherapy for Black women in study EAZ171 (story by the Susan G. Komen organization)

Do you like it?
Read more
June 13, 2024
June 13, 2024
Categories

EAZ171 trial suggests Black patients with breast cancer have lower risk of taxane-induced peripheral neuropathy with docetaxel than paclitaxel

Do you like it?
Read more
June 13, 2024
June 13, 2024
Categories

Study EAZ171 suggests docetaxel is superior for neuropathy in Black patients with breast cancer

Do you like it?
Read more
June 13, 2024
June 13, 2024
Categories

The June 2024 News from ECOG-ACRIN blog is now available

Do you like it?
Read more
June 3, 2024
June 3, 2024
Categories

Press Release: ECOG-ACRIN completes first trial of Black patients with early-stage breast cancer

Do you like it?
Read more
ECOG-ACRIN Cancer Research Group